Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimers Disease and Coyas Pathway to a Pipeline in a Product

COYA Stock   7.08  0.35  5.20%   
About 55% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that some traders are interested. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
  
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing multiple therapeutic programs inte

Read at businesswire.com
businesswire News
  

Coya Therapeutics, Fundamental Analysis

We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Coya Therapeutics, is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Coya Therapeutics, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.

Peers

Coya Therapeutics, Related Equities

NAMSWNewAmsterdam Pharma   19.37   
0%
100.0%
GANXGain Therapeutics   12.11   
0%
62.0%
INABIn8bio   8.00   
0%
41.0%
TCRXTscan Therapeutics   3.96   
0%
20.0%
CNTACentessa Pharmaceuticals   3.25   
0%
16.0%
STROSutro Biopharma   2.58   
0%
13.0%
FENCFennec Pharmaceuticals   2.18   
0%
11.0%
ABOSAcumen Pharmaceuticals   1.59   
0%
8.0%
HLVXHillevax   0.56   
2.0%
0%
CUECue Biopharma   0.81   
4.0%
0%
INZYInozyme Pharma   0.83   
4.0%
0%
LTRNLantern Pharma   1.00   
5.0%
0%
DRMADermata Therapeutics   1.72   
8.0%
0%
TERNTerns Pharmaceuticals   1.86   
9.0%
0%
CGTXCognition Therapeutics   2.17   
11.0%
0%
OPTOpthea   2.61   
13.0%
0%
DAWNDay One   4.03   
20.0%
0%

Complementary Tools for Coya Stock analysis

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like